Cantor Fitzgerald Reiterates Overweight Rating on Elevance (ELV)

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating and $485.00 price target on Elevance (NYSE: ELV).

The analyst commented, "We sense sentiment is turning incrementally more positive on ELV with a clean quarter, in contrast to UNH. ELV's cost trends remain elevated in all segments, but inline with guidance and pricing. If this holds, there could be room for modest upside to guidance and an argument that multiples have been overly impacted by adverse selection fears. There is a 4x delta in how ELV vs. CVS multiples have moved and 2x ELV vs. HUM since concerns of adverse selection were raised in September 2024. We maintain our overweight rating on ELV and $485 PT, 17% upside from current levels."

For an analyst ratings summary and ratings history on Elevance click here. For more ratings news on Elevance click here.

Shares of Elevance closed at $415.90 yesterday.

You May Also Be Interested In

• Alnylam Pharmaceuticals (ALNY) PT Lowered to $410 at Truist Securities
• Rubrik (RBRK) Reiterated at Overweight by Cantor Fitzgerald Amid U.K. Expansion
• Archer Aviation (ACHR) Reiterated at Overweight by Cantor Fitzgerald on EIPP Order